Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • Cardiac POC Testing Devices

    ... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More

  • Interventional Radiology Systems

    ... at a CAGR of 7.1% over the analysis period 2024-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.7 Billion by the end of ... Read More

  • Lateral Flow Assays

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end ... Read More

  • Biosensors

    ... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More

  • Renal Denervation Technologies

    ... at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based Renal Denervation, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the ... Read More

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • Proton Therapy

    ... CAGR of 13.5% over the analysis period 2024-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. ... Read More

  • RSV Diagnostics

    ... CAGR of 7.0% over the analysis period 2024-2030. RSV Diagnostic Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$686.6 Million by the end ... Read More

  • Over The Counter (OTC) Testing

    ... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 ... Read More

  • Ultrasound Image Analysis Software

    ... 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Integrated Software, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.2 Billion by the ... Read More

  • X-ray Inspection Systems

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Digital Imaging Technique, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$925.2 Million by the end ... Read More

  • Hepatitis Test Solution/Diagnosis

    ... at a CAGR of 6.0% over the analysis period 2024-2030. ELISA Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of ... Read More

  • Medical Digital Imaging Systems

    ... 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. X-Ray, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$12.9 Billion by the end ... Read More

  • Next Generation Cancer Diagnostics

    ... 2030, growing at a CAGR of 21.8% over the analysis period 2024-2030. qPCR & Multiplexing Technology, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$28.2 Billion ... Read More

  • Non-Invasive Prenatal Testing (NIPT)

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. NIPT Consumables & Reagents, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$5.5 Billion ... Read More

  • Elastography Imaging

    ... CAGR of 10.0% over the analysis period 2024-2030. Ultrasound Modality, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$6.1 Billion by the end of the analysis ... Read More

  • ELISpot and FluoroSpot Assay

    ... 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$464.4 Million by the ... Read More

  • Ultrasound Probe Disinfection

    ... at a CAGR of 8.0% over the analysis period 2024-2030. Ultrasound Probe Disinfection Instruments, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$427.6 Million by the ... Read More

  • Veterinary Rapid Testing

    ... at a CAGR of 8.3% over the analysis period 2024-2030. Rapid Testing Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end ... Read More

  • Veterinary X-ray

    ... CAGR of 6.6% over the analysis period 2024-2030. Computed Radiography, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$360.6 Million by the end of the analysis ... Read More

  • Near Infrared Imaging

    ... at a CAGR of 14.8% over the analysis period 2024-2030. Near Infrared Imaging Devices, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.7 Billion by the ... Read More

  • Cell Isolation / Cell Separation

    ... Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2024-2030. Cell Isolation / Cell Separation Consumables, one of the segments analyzed in the report, is expected to record a 19.5% CAGR ... Read More

  • Cell Viability Assays

    ... at a CAGR of 7.1% over the analysis period 2024-2030. Cell Viability Assay Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the ... Read More

  • Cervical Cancer Diagnostic Testing

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More

Cookie Settings